BIO-Europe Partnering Conference

Dr. Gábor Somlyai represented HYD Ltd. for Cancer Research and Drug Development and its mother company, HYD Pharma Inc. at the BIO-Europe Partnering Conference in Vienna between March 25 and 27, 2019.

More than 2400, primarily pharmaceutical, R&D, medical, financial and investment company took part in this remarkable event.

29 March 2019